Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Makmur Berkah Amanda Tbk (AMAN) vs Dharma Polimetal Tbk. (DRMA)

Makmur Berkah Amanda TbkTrading
Dharma Polimetal Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Makmur Berkah Amanda Tbk dan Dharma Polimetal Tbk.: Makmur Berkah Amanda Tbk diperdagangkan di Rp240 (kapitalisasi pasar 937,39 M, volume 24 jam 108,9 rb), sedangkan Dharma Polimetal Tbk. diperdagangkan di Rp985 (kapitalisasi pasar 4,64 T, volume 24 jam 358,7 rb). Perbedaan utamanya: Dharma Polimetal Tbk. jauh lebih besar — sekitar 4,9× kapitalisasi pasar Makmur Berkah Amanda Tbk, dan Dharma Polimetal Tbk. lebih aktif diperdagangkan (358,7 rb vs 108,9 rb). Mana yang lebih baik tergantung tujuan investasimu.

AMANDRMA
Kapitalisasi Pasar
937,39 M4,64 T
Volume
108,9 rb358,7 rb
Lot
1,09 rb3,59 rb
Perputaran
26,19 jt353,43 jt
Harga Rata-rata
240,46985,32
Nilai Transaksi
26,19 jt353,43 jt
Harga Ekuilibrium Indikatif
985
Volume Ekuilibrium Indikatif
54,6 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

AMAN
Lihat detail
DRMA
Lihat detail

Tentang Makmur Berkah Amanda Tbk

PT Makmur Berkah Amanda Tbk (previously PT Sidomaju Industri Estate ("Company")) was established based on Deed No.224, dated May 31, 1996 made by Erly Soehandjojo, SH, notary in Jakarta and Notary Deed Number 5 dated July 2, 1997 made Soeharto, SH, notary in Sidoarjo (here in after referred to as " The Deed of Establishment Deed"). The Company has began its commercial operations since May 31, 1996.

Selengkapnya di halaman AMAN

Tentang Dharma Polimetal Tbk.

PT Dharma Polimetal Tbk (“the Company”) was established in the Republic of Indonesia on 27 March based on Notarial deed No. 74 of Rukmasanti Hardjasatya, S.H. The Company begin opertions on year 1989 and commenced its commercial activities since 1990. The Company’s Majority shareholder is PT Dharma Inti Anugerah, established in Republic Indonesia on 20 November 2003.

Selengkapnya di halaman DRMA